Literature DB >> 23517188

Multifaceted transport characteristics of nanomedicine: needs for characterization in dynamic environment.

Altug Ozcelikkale1, Soham Ghosh, Bumsoo Han.   

Abstract

Nanomedicine for cancer, where nanoparticles (NPs) are used to deliver drugs, imaging agents, and heat to tumors, shows great potential of improved therapeutic outcomes. In spite of promising early stage results, its clinical efficacy is still significantly limited due to complex transport barriers in vivo. These transport barriers are associated with tumor microenvironment, which is highly complex and heterogeneous and varies spatiotemporally. Thus, in order to improve the in vivo efficacy of nanomedicine, NPs need to be designed and characterized considering their interaction with these complex transport barriers. In this article, thus, we discuss the multifaceted transport characteristics of NPs and their interaction mechanisms with the tumor microenvironment. We also illustrated that NPs have highly spatiotemporal and multiscale distribution around tumor. This dynamic and complex nature of NP transport needs to be taken into consideration in design strategies and evaluation criteria for successful delivery of cancer nanomedicine.

Entities:  

Mesh:

Year:  2013        PMID: 23517188     DOI: 10.1021/mp3005947

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  14 in total

Review 1.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

Review 2.  In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.

Authors:  Altug Ozcelikkale; Hye-Ran Moon; Michael Linnes; Bumsoo Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-14

3.  In Vitro Assays for Nanoparticle-Cancer Cell Interaction Studies.

Authors:  Tomás Bauleth-Ramos; Bruno Sarmento
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.

Authors:  Bumsoo Han; Chunjing Qu; Kinam Park; Stephen F Konieczny; Murray Korc
Journal:  Cancer Lett       Date:  2015-12-10       Impact factor: 8.679

5.  Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model.

Authors:  Altug Ozcelikkale; Kyeonggon Shin; Victoria Noe-Kim; Bennett D Elzey; Zizheng Dong; Jian-Ting Zhang; Kwangmeyung Kim; Ick Chan Kwon; Kinam Park; Bumsoo Han
Journal:  J Control Release       Date:  2017-09-20       Impact factor: 9.776

Review 6.  Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under Uncertainty.

Authors:  Ali Aykut Akalın; Barış Dedekargınoğlu; Sae Rome Choi; Bumsoo Han; Altug Ozcelikkale
Journal:  Pharm Res       Date:  2022-06-01       Impact factor: 4.580

7.  Characterization of Cell-Type-Specific Drug Transport and Resistance of Breast Cancers Using Tumor-Microenvironment-on-Chip.

Authors:  Kyeonggon Shin; Brett S Klosterhoff; Bumsoo Han
Journal:  Mol Pharm       Date:  2016-06-10       Impact factor: 4.939

8.  Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip.

Authors:  Bongseop Kwak; Altug Ozcelikkale; Crystal S Shin; Kinam Park; Bumsoo Han
Journal:  J Control Release       Date:  2014-09-03       Impact factor: 9.776

9.  Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.

Authors:  Liu Xu; Yutong Wang; Chenqi Zhu; Shujing Ren; Yurou Shao; Li Wu; Weidong Li; Xiaobin Jia; Rongfeng Hu; Rui Chen; Zhipeng Chen
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

Review 10.  Development of MicroRNAs as Potential Therapeutics against Cancer.

Authors:  Noraini Abd-Aziz; Nur Izyani Kamaruzman; Chit Laa Poh
Journal:  J Oncol       Date:  2020-07-15       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.